Latest news
Macular Society partners with UK’s largest health research programme
Posted: Friday 5 April 2024
The Macular Society is proud to announce a new partnership with Our Future Health, a groundbreaking initiative aimed at revolutionising research into health conditions such as age-related macular degeneration (AMD).
Find out more
Home monitoring for patients with AMD
Posted: Wednesday 3 April 2024
Health tech startup OKKO Health has shared new insights from its UK research study on home monitoring for age-related macular degeneration (AMD). The study is being carried out in collaboration with the Macular Society.
Find out more
Discover the latest news on treatments and emerging drugs
Posted: Tuesday 2 April 2024
A webinar exploring the fast-changing landscape of treatments for age-related macular degeneration (AMD) will be hosted by OcuPlan this month.
Find out more
‘Regular injections essential in maintaining vision’
Posted: Wednesday 27 March 2024
Early diagnosis, prompt initial treatment, and regular injections help stabilise vision in most eyes with wet age-related macular degeneration (AMD), according to a new report published by the Royal College of Ophthalmologists
Find out more
All you need to know about implantable magnifying lenses for macular disease
Posted: Monday 25 March 2024
Intraocular lenses (IOLs) were the focus of our My Macular and Me webinar in March, as Dr Julie Silvestri shed light on the potential of these devices, which aim to improve vision for people living with sight loss.
Find out more
‘I didn’t appreciate the longer-term emotional impact of this disease’
Posted: Wednesday 20 March 2024
Jill, a university researcher from County Durham, described how the Macular Society’s Counselling Service gave her the “time and breathing space” to adapt after a diagnosis of an extremely rare form of macular disease.
Find out more
Enquiry explores employers’ attitudes to visually impaired employees
Posted: Tuesday 5 March 2024
The All Party Parliamentary Group (APPG) on Eye Health and Visual Impairment has launched an enquiry to find out more about how employers treat and hire blind and partially sighted people.
Find out more
Increased dose of Eylea to extend treatment intervals
Posted: Friday 1 March 2024
Renowned retinal specialist Dr Kenneth Fan has called the higher approved dose of Eylea for patients with wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO), “a pivotal moment” for the treatment of these conditions.
Find out more
Encouraging results from light therapy study for dry AMD
Posted: Friday 1 March 2024
Early results from a study assessing the effectiveness of the Valeda Light Delivery System for treating dry age-related macular degeneration (AMD), have shown promise.
Find out more
'Talking about it is an opportunity to help people understand more about sight loss'
Posted: Thursday 29 February 2024
Leah's journey with Best disease started when she was growing up with her brother Finn, who has the condition. But, even though she knew what it was, her own eyesight was not affected.
Find out more
Patients reveal communication gaps in diagnosis
Posted: Monday 5 February 2024
Patients have highlighted noticeable gaps in communication when they are first diagnosed with macular disease, or if they are considered at risk of developing the condition.
Find out more
'The more that is known about Charles Bonnet syndrome, the better'
Posted: Thursday 1 February 2024
Researchers at Royal Holloway University looking into the effectiveness of different techniques to help manage visual hallucinations are calling for more participants to take part in the first study of its kind.
Find out more
Get the latest news and advice from the Macular Society
To hear about life-changing research, treatments and tips for living with sight loss, subscribe to our monthly enewsletter today. Together we can Beat Macular Disease.
Sign up to our free email newsletter